EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Left ventricular reverse remodelling after mitral transcatheter edge-to-edge repair: results from the EXPANDed studies

Mirjam Keßler, Gilbert H L Tang, Sébastien Deferm iD, Rodrigo Estevez-Loureiro, Wolfgang Rottbauer iD, Federico M Asch iD, Jose L Zamorano, Janani Aiyer, Rong Huang, Evelio Rodriguez, Saibal Kar iD, Francesco Maisano und 1 weitere

ESC Heart Failure · 05.05.2026 · 13 (3)

DOI: 10.1093/eschf/xvag081 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 16.03.2026. Verfasst von Mirjam Keßler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany. Hauptthemen laut MEDLINE: Cardiac Catheterization, Heart Failure, Mitral Valve Insufficiency, Ventricular Function, Left. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abbott.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Left ventricular reverse remodelling (LVRR) is a key objective of contemporary heart failure (HF) therapies and is characterized by reversal of left ventricular (LV) dilation and dysfunction.

Objectives

To report the incidence and clinical impact of early (30-day) LVRR patients with primary (PMR) and secondary mitral regurgitation (SMR) treated with mitral transcatheter edge-to-edge repair (M-TEER), and to identify independent associations with early LVRR.

Methods

The EXPANDed cohort includes 2205 patients treated with M-TEER from the EXPAND and EXPAND G4 studies. Patients were classified as having early LVRR if they demonstrated a >10% reduction in LV dimension or volume from baseline to 30 days. All LV measurements were assessed by independent echocardiographic core laboratories.

Results

Among 527 SMR patients, 338 patients (64.1%) experienced early LVRR after M-TEER. At 1 year, SMR patients with early LVRR had significantly lower rates of death or HF hospitalizations compared with those without (early LVRR: 24.7% vs no early LVRR: 35.9%, P = .009), despite similar MR reduction (MR mild or less ≥93% in both groups) and comparable improvements in functional status (NYHA ≤II ≥78%) and quality of life (∼20-points improvement per KCCQ-OS). Independent associations with early LVRR included hypertension [odds ratio (OR) = 1.96, P = .004], absence of prior cardiac surgeries (OR = 0.51, P = .002), and smaller LV end-systolic volume (OR = 0.81, P = .002). Among 536 PMR patients, 391 (73.0%) experienced early LVRR at 30 days. At 1 year, PMR patients with early LVRR group had similar clinical (composite all-cause mortality or HF hospitalization: early LVRR: 14.5% vs no early LVRR: 17.1%, P = .47) and symptomatic outcomes (≥83% NYHA ≤II; ∼19-point improvement per KCCQ-OS) compared with those without. However, among PMR patients with dilated ventricles, early LVRR group was associated with significantly lower all-cause mortality (early LVRR: 3.8%, no Early LVRR: 14.0%, P = .028).

Conclusions

Regardless of aetiology, most patients experienced early LVRR after M-TEER with significant MR reduction and symptom relief. In SMR patients, early LVRR was associated with lower rates of HF hospitalization and death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac CatheterizationHeart FailureMitral Valve InsufficiencyVentricular Function, LeftVentricular RemodelingAgedFemaleHumansMaleEchocardiographyFollow-Up StudiesHeart VentriclesMitral ValveStroke Volume

Stichwörter der Autor:innen

Left ventricular reverse remodellingMitral regurgitationMitral valve repairPrimary mitral regurgitationSecondary mitral regurgitationTranscatheter edge-to-edge repair (TEER)

Autor:innen und Institutionen

  • Ulm University Heart Center, University of Ulm, Albert-Einstein-Allee 23, 89081 Ulm, Germany.
  • Department of Cardiovascular Surgery, Mount Sinai Hospital, NewYork, NY, USA.
  • Department of Cardiology, Hospital Oost-Limburg, Genk, Belgium.
  • Interventional Cardiology, Hospital Alvaro Cunqueiro, Vigo, Pontevedra, Spain.
  • Cardiovascular Core Laboratories, MedStar Health Research Institute, Washington, DC, USA.
  • Department of Cardiology, Hospital Ramon y Cajal, Madrid, Spain.

ORCID-Profile: Sébastien Deferm, Wolfgang Rottbauer, Federico M Asch, Saibal Kar

Förderung

  • Abbott

Zitieren

APA

Keßler, M., Tang, G. H. L., Deferm, S., Estevez-Loureiro, R., Rottbauer, W., Asch, F. M., Zamorano, J. L., Aiyer, J., Huang, R., Rodriguez, E., Kar, S., Maisano, F., & von Bardeleben, R. S. (2026). Left ventricular reverse remodelling after mitral transcatheter edge-to-edge repair: results from the EXPANDed studies. ESC Heart Failure, 13(3). https://doi.org/10.1093/eschf/xvag081

Vancouver

Keßler M, Tang GHL, Deferm S, Estevez-Loureiro R, Rottbauer W, Asch FM, et al. Left ventricular reverse remodelling after mitral transcatheter edge-to-edge repair: results from the EXPANDed studies. ESC Heart Failure. 2026;13(3). doi:10.1093/eschf/xvag081

BibTeX
@article{Keler2026,
  author = {Keßler, Mirjam and Tang, Gilbert H L and Deferm, Sébastien and Estevez-Loureiro, Rodrigo and Rottbauer, Wolfgang and Asch, Federico M and Zamorano, Jose L and Aiyer, Janani and Huang, Rong and Rodriguez, Evelio and Kar, Saibal and Maisano, Francesco and von Bardeleben, Ralph Stephan},
  title = {Left ventricular reverse remodelling after mitral transcatheter edge-to-edge repair: results from the EXPANDed studies},
  journal = {ESC Heart Failure},
  year = {2026},
  volume = {13},
  number = {3},
  doi = {10.1093/eschf/xvag081}
}
Kostenlos starten →